Multi-product PrEP Delivery to Young Women Seeking Reproductive Health Services and Coverage of HIV Prevention
Recruiting now · Phase 4
Conditions studied: Hiv
In brief
Following on the heels of large implementation science projects that participated in the launch of widespread daily oral PrEP availability, investigators will launch and study the integration of novel PrEP products - beginning with the dapivirine ring- into existing PrEP programs that reach women seeking reproductive health care at health facilities in Kenya. Intervention delivery will be launched among 12 participating clinics with approximately 1400 AGYW seeking reproductive health services and counseled about PrEP through a stepped wedge cluster randomized trial. investigators will support participating clinics to add dapivirine ring into their existing PrEP services offered to women seeking reproductive health care. The primary aim of the study will be to determine whether the availability of multiple PrEP products to young women will result in greater frequency of PrEP initiation and persistence.
Key facts
- Study ID
- NCT07076043
- Run by
- University of Alabama at Birmingham
- People needed
- 1400
- Starts
- 2025-06-03
- Expected to finish
- 2029-12-30
- Last updated by the study team
- 2026-07-22
Who can join
Age: 18 and older, up to 30. Sex: female. Healthy volunteers: accepted.
Where it is running
- Kenya Medical Research Institute and Partners in Health & Research Development — Thika, Kiambu County, Kenya (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.